Study: Hispanic Adults, Women, and Older E-cigarette Users Face Higher Odds of Asthma and COPD
CHEST 2021: Study shows vaping raises the odds of developing asthma and COPD, especially in older adults, women, and Hispanic persons.
Dupilumab Associated with Reduced Oral Corticosteroids in Severe Asthma, Regardless of Baseline OCS Dose
In patients with severe asthma dependent on OCS, dupilumab reduced OCS dose and improved the odds of no longer requiring OCS, suggests research presented at CHEST 2021.
Tezepelumab May Improve Peak Expiratory Flow in Patients with Severe Asthma, Suggests Analysis of NAVIGATOR Trial
CHEST 2021: Patients with severe asthma who received tezepelumab compared with placebo demonstrated rapid improvement in morning and evening peak expiratory flow.
Multidisciplinary Asthma Care: It Takes a Village
Effective asthma care requires attention to comorbidities, complications, and human characteristics of each patient. Speakers at CHEST 2015 described "the village."
Clinical Evolution in Asthma and COPD
New approaches discussed at CHEST 2015 ranged from the impact of bariatric surgery on asthma control to endobronchial valve placement in COPD.
Emerging Pharmacotherapy in COPD: Update from CHEST 2015
In a well-attended session at CHEST 2015 a number of promising new therapies for treating COPD were reviewed by study authors.
Safety of COPD Medications: Current Evidence
COPD is one of the primary lung diseases seen in primary care. A CHEST 2015 panel session reinforced that treatment is often a risk/benefit balance.
Consistent Asthma Control: One Patient at a Time
The best asthma care is not good enough if the patient is nonadherent. Applied "humanomics" as an approach to chronic care was discussed this week at CHEST 2015.
Primary Care Management of Multimorbidity: COPD, for Example
Exacerbations of COPD often complicate CV outcomes. Two studies presented at CHEST 2015 looked at ways to refine risk factors for CV decline.
Steroid-sparing Rx for Severe Asthma: What is In the Pipeline?
Severe refractory asthma resists conventional therapies, but a roster of new biologics, discussed at CHEST 2015 in Montreal, may soon offer relief.
FeNO: An Adjunct for Asthma Management in Primary Care?
Study results revealed at CHEST 2015 showed use of FeNO to assess inflammation led family physicians to change steroid dose in 50% of asthma patients.
Asthma-COPD Overlap Syndrome: Sharpen Suspicion in Primary Care
ACOS is often first suspected in the primary care setting. Experts at CHEST 2015 reviewed the syndrome, who is at risk, and treatment challenges.
Asthma, Plus Age and Illness, in the Elderly
Aging and comorbidities make asthma management in the elderly much more difficult than in younger people. Get a quick look here at what to watch out for.
